Advertisement

Topics

Latest "Rentschler Fill Solutions GmbH" News Stories

15:08 EST 18th January 2019 | BioPortfolio

Here are the most relevant search results for "Rentschler Fill Solutions GmbH" found in our extensive news archives from over 250 global news sources.

More Information about Rentschler Fill Solutions GmbH on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Rentschler Fill Solutions GmbH for you to read. Along with our medical data and news we also list Rentschler Fill Solutions GmbH Clinical Trials, which are updated daily. BioPortfolio also has a large database of Rentschler Fill Solutions GmbH Companies for you to search.

Showing "Rentschler Fill Solutions GmbH" News Articles 1–25 of 7,100+

Extremely Relevant

Rentschler opens GMP fill/finish facility in Austria

Aseptic fill/finish contractor Rentschler Fill Solutions inaugurated the new facility in Austriaâs eastern town of Rankweil.


Rentschler Fill Solutions Granted GMP Certificate

For the European market from the Austrian Agency for Health and Food Safety

Rentschler Fill Solutions Makes Key Hire

With over two decades experience, Dr. Margit Klotz joins the company as general manager, Operations


Rentschler Fill Solutions names General Manager Operations

Dr Margit Klotz to oversee Process Development & Manufacturing, Quality and Engineering, effective 1 August 2018

Rentschler Appoints New VP of Manufacturing Science and Technology

Henning Gerschewski joined Rentschler Biopharma as vice president, manufacturing science and technology. Gerschewski has more than 15 years of experience in cell culture cultivation, downstream processing, and technology transfer. “We are happy to welcome Henning Gerschewski back to the Rentschler family,” Ralf Otto, COO, Rentschler, told GEN. “We believe that his exceptional knowledge and t...

Relevant

Rentschler Inaugurates New Fill and Finish Facility

New high-tech facility to be used for the aseptic filling and freeze-drying of drug products

Rentschler Biopharma Completes Acquisition of U.S. Mfg. Site

Rentschler will continue to manufacture for Shire at the 93,000 sq.-ft. site in Milford, MA

Rentschler sets up shop in the US with plans to grow CDMO services

A âstrong client requestâ has prompted the CDMO Rentschler Biopharma to acquire its first US-based facility, which will provide various development and manufacturing services.

Rentschler Biopharma to purchase US manufacturing site from Shire

Under the terms of the agreement, Rentschler Biopharma will continue to manufacture product for Shire at the site

Q&A: McKesson HVS’ Tamarro talks customized central fill

Q&A: McKesson HVS’ Tammaro talks customized central fill

Rentschler Appoints New VP of Manufacturing Science and Technology: http://ow.ly/vAz630ngp3o pic.twitter.com/C6LeeTxYXF

Rentschler Appoints New VP of Manufacturing Science and Technology: http://ow.ly/vAz630ngp3o  pic.twitter.com/C6LeeTxYXF

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A group of private investors invests together with beteiligungsmanagement thüringen GmbH (bm|t) in onc...

Rentschler Biotechnologie GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryRentschler Biotechnologie GmbH Rentschler, a subsidiary of Dr. Rentschler Holding GmbH Co KG is a contract development and manufacturing organization that develops and manufactures biopharmaceuticals. The organization offers bioprocess development, biomanufacturing, and consulting services. Its product include recombinant proteins, such as complex glycoproteins and fusion proteins. Rentsch...

Rentschler Biotechnologie GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryRentschler Biotechnologie GmbH Rentschler, a subsidiary of Dr. Rentschler Holding GmbH Co KG is a contract development and manufacturing organization that develops and manufactures biopharmaceuticals. The organization offers bioprocess development, biomanufacturing, and consulting services. Its product include recombinant proteins, such as complex glycoproteins and fusion proteins. Rentsch...

Rentschler Biopharma completes acquisition of US manufacturing site

Company s first foothold in the US grants access to new technologies, innovation and talent

Miltenyi Biotec acquires microscopy specialist

Miltenyi Biotec GmbH announced that it has acquired the high-end microscopy specialist LaVision BioTec GmbH. Located in Bielefeld, Germany, LaVision BioTec is a leading global specialist for advanced light-sheet and multiphoton microscopy solutions for life science applications. Since its foundation...

Rentschler Biopharma Appoints Mfg. VP

With over 15 years experience, Henning Gerschewski will serve as vice president Manufacturing Science and Technology, effective January 01, 2019.

Rentschler Biopharma Buys U.S. Mfg. Site from Shire

Will leverage the development and manufacturing site for CDMO services

Central fill’s patient care proposition

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in...

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In...

MCI nod to fill additional MBBS seats after completion of admission process puts KNRUHS in a fix

With the Medical Council of India (MCI) giving its nod to fill up 300 additional MBBS seats in some of the private colleges of which 75 seats fall under convenor quota, the management of Kalaoji Narayan Rao University of Health Sciences

Blow-fill-seal Technology Market Worth $386.0 Million by 2023

CHICAGO, September 25, 2018 /PRNewswire/ -- According to the new market research report on the "Blow-fill-seal Technology Market by Material (Polypropylene & Polyethylene), Product (Bottles, Read more...

Rentschler Biopharma Appoints Innovation SVP

Dr. Jesús Zurdo will provide scientific leadership for development and manufacturing services from cell-line development through to final product manufacturing


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks